Evidence map›Paper›PMID 22095660›Full record

ArticleHepatology (Baltimore, Md.)2012

Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice.

Tsuyoshi Ishikawa, Valentina M Factor, Jens U Marquardt, Chiara Raggi, Daekwan Seo, Mitsuteru Kitade, Elizabeth A Conner, Snorri S Thorgeirsson

Open access · bronzeAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 189 citations in OpenAlex.

  1. Article
  2. Article
  3. 6-Antioxidants (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A Protocol for the Isolation of Oval Cells without Preconditioning.International journal of molecular sciences · 2024
    Article
  15. Review
  16. Review
  17. New and Old Key Players in Liver Cancer.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Article
  20. Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tsuyoshi IshikawaLaboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4262, USA.
Valentina M Factor
Jens U Marquardt
Chiara Raggi
Daekwan Seo
Mitsuteru Kitade
Elizabeth A Conner
Snorri S Thorgeirsson
National Cancer Institute · USCenter for Cancer Research · USNational Institutes of Health · US

Funding

The role of c-met in liver biologyZIABC010638 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI THORGEIRSSON, SNORRI · 2009 to 2013
$1.0M
Intramural NIH HHS ZIA BC010638
6 · The paper itself

Abstract

unlabelledHepatocyte growth factor (HGF)/c-Met supports a pleiotrophic signal transduction pathway that controls stem cell homeostasis. Here, we directly addressed the role of c-Met in stem-cell-mediated liver regeneration by utilizing mice harboring c-met floxed alleles and Alb-Cre or Mx1-Cre transgenes. To activate oval cells, the hepatic stem cell (HSC) progeny, we used a model of liver injury induced by diet containing the porphyrinogenic agent, 3,5-diethocarbonyl-1,4-dihydrocollidine (DDC). Deletion of c-met in oval cells was confirmed in both models by polymerase chain reaction analysis of fluorescence-activated cell-sorted epithelial cell adhesion molecule (EpCam)-positive cells. Loss of c-Met receptor decreased the sphere-forming capacity of oval cells in vitro as well as reduced oval cell pool, impaired migration, and decreased hepatocytic differentiation in vivo, as demonstrated by double immunofluorescence using oval- (A6 and EpCam) and hepatocyte-specific (i.e. hepatocyte nuclear factor 4-alpha) antibodies. Furthermore, lack of c-Met had a profound effect on tissue remodeling and overall composition of HSC niche, which was associated with greatly reduced matrix metalloproteinase (MMP)9 activity and decreased expression of stromal-cell-derived factor 1. Using a combination of double immunofluorescence of cell-type-specific markers with MMP9 and gelatin zymography on the isolated cell populations, we identified macrophages as a major source of MMP9 in DDC-treated livers. The Mx1-Cre-driven c-met deletion caused the greatest phenotypic impact on HSCs response, as compared to the selective inactivation in the epithelial cell lineages achieved in c-Met(fl/fl); Alb-Cre(+/-) mice. However, in both models, genetic loss of c-met triggered a similar cascade of events, leading to the failure of HSC mobilization and death of the mice.

conclusionThese results establish a direct contribution of c-Met in the regulation of HSC response and support a unique role for HGF/c-Met as an essential growth-factor-signaling pathway for regeneration of diseased liver.

Indexed as

AnimalsCell DifferentiationCell MovementChemical and Drug Induced Liver InjuryChemokine CXCL12Disease Models, AnimalHepatocyte Growth FactorLiver RegenerationMaleMatrix Metalloproteinase 9MiceMice, Mutant StrainsMice, TransgenicProto-Oncogene Proteins c-metPyridinesSignal Transduction3,5-diethoxycarbonyl-1,4-dihydrocollidineChemokine CXCL12Hepatocyte Growth FactorMatrix Metalloproteinase 9Proto-Oncogene Proteins c-metPyridines

Identifiers

PMID22095660
PMCPMC3299882
OpenAlexW2056510085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.